- Rheumatoid arthritis
- Juvenile idiopathic arthritis
- Axial spondyloarthritis
- Psoriatic arthritis
- Psoriasis
- Paediatric plaque psoriasis
- Hidradenitis suppurativa (HS)
- Crohn's disease
- Paediatric Crohn's disease
- Ulcerative colitis
- Paediatric ulcerative colitis
- Uveitis
- Paediatric Uveitis
Idacio®
(adalimumab)
- Filename
- idacioprescribinginformation2024.pdf
- Size
- 1 MB
- Format
Details
- Indication
- Presentation and order codes
The Idacio 40mg solution for injection in a pre-filled pen and pre-filled syringe are indicated for use in the following conditions. Please consult the SmPC before prescribing. Idacio treatment should be initiated and supervised by specialist physicians experienced in the diagnosis and treatment of conditions for which Idacio is indicated.
Item code | Description | Presentation | Case Qty |
F0910202 | Idacio 40mg | Pre filled syringe 0.8ml | 2 |
F0910203 | Idacio 40mg | Pre filled pen 0.8ml | 2 |
Adverse events should be reported. Reporting forms and information can be found at: https://yellowcard.mhra.gov.uk Adverse events should also be reported to Fresenius Kabi Ltd. Cestrian Court, Eastgate Way, Manor Park, Runcorn, Cheshire, WA7 1NT Tel +44 (0)1928 533 575. Email:
GB-IDA-2400016 October 2024